Raju Mohan - 02 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
02 Dec 2022
Net transactions value
-$8,691,087
Form type
4
Filing time
06 Dec 2022, 16:00:34 UTC
Previous filing
04 Feb 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $8,036,957 -276,997 -15% $29.01 1,564,814 02 Dec 2022 Direct F1
transaction VTYX Common Stock Sale $563,560 -19,896 -1.3% $28.33 1,544,918 05 Dec 2022 Direct F2
transaction VTYX Common Stock Sale $90,569 -3,107 -0.2% $29.15 1,541,811 05 Dec 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 276,997 shares sold in the price range of $28.865 to $29.21. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 19,896 shares sold in the price range of $28.08 to $29.0623. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 3,107 shares sold in the price range of $29.12 to $29.89. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.